RxDoctor Payments Data

Fatima Tsalikova, MD

Family Medicine · Westerville, OHNPI 1659586360

Payments from drug & device makers

$395in general payments, 2019–2025

Across 22 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$194
  • Otsuka America Pharmaceutical, Inc.$67
  • Philips North America LLC$39
  • Sanofi$32
  • Xeris Pharmaceuticals, Inc.$19
  • Novo Nordisk$17
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$395100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$395 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$170,408
Medicare patients
233
Services billed
5,325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$85,693
RybelsusSemaglutide37$70,026
FarxigaDapagliflozin Propanediol49$61,153
JardianceEmpagliflozin39$53,773
MounjaroTirzepatide36$47,749
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$42,142
TrulicityDulaglutide28$37,473
OzempicSemaglutide14$24,532
Breo ElliptaFluticasone/Vilanterol24$23,865
JanuviaSitagliptin Phosphate13$20,601
XareltoRivaroxaban12$16,212
Tresiba Flextouch U-200Insulin Degludec24$15,115
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$10,611
Novolog FlexpenInsulin Aspart13$5,420
Clonidine19$4,896

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$17$94,55851 claims
AbbVieSynthroid$14$1,27942 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →